First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature.
The occurrence of supraventricular tachycardia after high-dose intravenous methylprednisolone pulse therapy (HIVMPT) in a patient with active rheumatoid arthritis is described for the first time. This case report further expands the range of arrhythmias that can occur with HIVMPT. Other arrhythmias previously reported to occur after HIVMPT include atrial fibrillation, atrial flutter, junctional rhythm, and ventricular tachycardia. To the best of our knowledge, supraventricular tachycardia has not been reported previously, although severe bradycardia, hypotension, asystole, cardiovascular collapse, and sudden death have been documented. A review of the literature indicates that these case reports not withstanding, HIVMPT is generally safe, and cardiovascular toxicity is rare. However, close supervision with repeated measurements of blood pressure, electrocardiogram, and blood electrolytes is mandatory during and immediately after HIVMPT, especially for patients with pre-existing cardiovascular disease, and the lowest effective dose of methylprednisolone should be infused at a slow rate.
Kumari
Rakesh
R
Rheumatology Division, Department of Medicine, Mubarak Al Kabeer Hospital, Kuwait.
Uppal
S S
SS
D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D020551:Pulse Therapy, Drug; D013617:Tachycardia, Supraventricular / Q000139:chemically induced* / Q000503:physiopathology
D005938:Glucocorticoids; D008775:Methylprednisolone
Pediatr Nephrol. 1988 Jan;2(1):29-31
3152997
Am J Kidney Dis. 1998 Jul;32(2):E4
10074612
Int J Cardiol. 1992 Aug;36(2):234-5
1512065
Ann Intern Med. 1981 Jul;95(1):122
7247116
Drug Saf. 2000 Nov;23(5):449-61
11085349
Scand J Rheumatol Suppl. 1984;54:27-32
6385227
Am J Ther. 2001 Jul-Aug;8(4):303-5
11441330
Nephron. 1998 Dec;80(4):484
9832654
Pediatrics. 1980 May;65(5):989-94
6966050
Ann Intern Med. 1981 Dec;95(6):781-2
7305165
Eur J Neurol. 2000 Jan;7(1):130
10809932
Ann Intern Med. 1981 Jan;94(1):21-6
7447218
Transplantation. 1999 Jun 15;67(11):1497-8
10385096
J Rheumatol. 1986 Apr;13(2):477-9
3723518
Scand J Rheumatol. 1986;15(3):302-4
3798047
Clin Rheumatol. 1984 Mar;3(1):29-31
6467850
Pediatr Hematol Oncol. 1993 Jul-Sep;10(3):v-vii
8217535
Arch Intern Med. 2001 Jul 23;161(14):1778-9
11485514
Br J Rheumatol. 1991 Oct;30(5):392-3
1913018
Presse Med. 1984 May 12;13(20):1269-71
6232585
Am J Nephrol. 1990;10(3):231-6
1696428
Ann Intern Med. 1986 Jan;104(1):58-9
3510055
Ann Pharmacother. 1992 Mar;26(3):316-20
1554949
DICP. 1989 Dec;23(12):1019-23
2690471
Semin Arthritis Rheum. 2003 Jun;32(6):370-7
12833245
Chest. 1993 Aug;104(2):622-3
8339660
J Rheumatol. 1988 Feb;15(2):242-6
3283356